Physician profile
Scott Kane
NPI 1265625313
$1,903.82
in general payments reported to CMS, 2019-2025
13 companies · $485 in 2025
The $485 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $324 · 2022: $387 · 2023: $607 · 2024: $100 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,192.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $502.62 | 2021-2025 | Caplyta |
| Neuronetics, INC. | $222.74 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $206.17 | 2021-2023 | Austedo |
| Neurocrine Biosciences, INC. | $135.72 | 2025 | |
| Lilly USA, LLC | $125.00 | 2025 | Zepbound |
| Alkermes, INC. | $119.99 | 2023 | Lybalvi |
| Novo Nordisk INC | $111.31 | 2025 | Wegovy |
| Otsuka America Pharmaceutical, INC. | $104.85 | 2021 | |
| Corium, LLC | $104.33 | 2022 | |
| Idorsia Pharmaceuticals US INC | $100.96 | 2023 | Quviviq |
| Abbvie INC. | $92.22 | 2023 | |
| Arthrex, INC. | $60.00 | 2023 | |
| Tempus Ai, INC | $17.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Kane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.